Sale!

MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the MYH6 gene associated with congenital heart defects. This comprehensive test utilizes Next Generation Sequencing technology to provide detailed insights into inherited cardiac conditions. Individuals with family history of atrial septal defects, unexplained heart murmurs, or congenital heart abnormalities should consider this test. Early detection enables proactive management and personalized treatment strategies. The test costs $500 USD and provides results within 3-4 weeks using blood, extracted DNA, or FTA card samples. Genetic counseling is recommended before testing to understand family inheritance patterns.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test

Comprehensive Introduction to Cardiac Genetic Testing

The MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing method specifically targets mutations in the MYH6 gene, which encodes the alpha-heavy chain subunit of cardiac myosin. This protein plays a crucial role in heart muscle contraction and development, making it essential for proper cardiac function from embryonic stages through adulthood.

Atrial septal defects (ASD) are among the most common congenital heart abnormalities, affecting approximately 1 in 1,500 live births. Type 3 atrial septal defects, specifically linked to MYH6 gene mutations, represent a significant hereditary component in cardiovascular disorders. Early identification through genetic testing can transform patient outcomes by enabling proactive medical management and personalized treatment approaches.

What This Advanced Test Detects

The MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test employs cutting-edge Next Generation Sequencing technology to comprehensively analyze the entire MYH6 gene. This sophisticated approach detects:

  • Point mutations affecting protein structure and function
  • Insertion and deletion variants disrupting gene expression
  • Missense mutations altering cardiac myosin heavy chain activity
  • Frameshift mutations leading to truncated proteins
  • Splice site variants affecting mRNA processing

This comprehensive analysis provides detailed information about genetic variations that may predispose individuals to congenital heart defects, particularly atrial septal abnormalities that can impact cardiac function throughout life.

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This specialized genetic test is particularly recommended for individuals experiencing or displaying:

  • Family history of congenital heart defects, especially atrial septal abnormalities
  • Unexplained heart murmurs detected during physical examinations
  • Recurrent respiratory infections in childhood suggesting underlying cardiac issues
  • Fatigue or exercise intolerance without clear explanation
  • Previous diagnosis of atrial septal defect requiring genetic correlation
  • Planning pregnancy with family history of cardiac genetic disorders
  • Abnormal echocardiogram findings suggestive of septal defects

High-Risk Populations

Individuals with first-degree relatives diagnosed with MYH6-related cardiac conditions should strongly consider genetic testing. Early identification in asymptomatic family members can facilitate timely interventions and monitoring strategies.

Significant Benefits of Genetic Testing

Undergoing the MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test provides numerous advantages for patients and healthcare providers:

  • Early Intervention Opportunities: Identify genetic predispositions before clinical symptoms manifest
  • Personalized Treatment Plans: Develop targeted management strategies based on genetic profile
  • Family Planning Guidance: Make informed reproductive decisions with genetic counseling support
  • Proactive Monitoring: Implement appropriate cardiac surveillance for at-risk individuals
  • Reduced Diagnostic Uncertainty: Provide definitive answers about hereditary cardiac conditions
  • Comprehensive Risk Assessment: Understand complete genetic landscape for informed healthcare decisions

Understanding Your Genetic Test Results

Result Interpretation Framework

Your MYH6 genetic test results will fall into one of several categories, each with specific clinical implications:

  • Positive Result: Indicates presence of known pathogenic mutation associated with increased atrial septal defect risk. Requires consultation with cardiologist and genetic counselor for comprehensive management plan.
  • Negative Result: No detected mutations in analyzed MYH6 regions. Significantly reduces but does not eliminate congenital heart defect risk, as other genetic or environmental factors may contribute.
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unknown clinical impact. Requires periodic re-evaluation as scientific knowledge advances.
  • Carrier Status: Important for family planning decisions, particularly when both partners carry mutations.

Post-Test Recommendations

All results should be discussed with qualified healthcare professionals, including cardiologists and genetic counselors, who can provide personalized guidance based on your specific genetic findings and clinical context.

Test Details and Pricing Information

Test Component Details Price (USD)
Test Name MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test
Discount Price Limited time special offer $500
Regular Price Standard pricing $700
Turnaround Time Comprehensive analysis period 3-4 Weeks
Sample Type Multiple collection options available Blood, Extracted DNA, or FTA Card
Testing Method Advanced genetic technology Next Generation Sequencing

Pre-Test Preparation Requirements

To ensure optimal testing outcomes, please prepare the following before your appointment:

  • Complete clinical history documentation focusing on cardiac symptoms and family medical background
  • Schedule genetic counseling session to develop comprehensive family pedigree chart
  • Identify affected family members for accurate inheritance pattern analysis
  • Discuss testing implications with healthcare provider to establish realistic expectations

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards regardless of location.

Take Control of Your Cardiac Health Today

Don’t leave your heart health to chance. The MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test provides crucial insights that can guide your healthcare journey for years to come. Our experienced team of genetic specialists and cardiologists are ready to support you through every step of the testing process.

Ready to begin your genetic health assessment? Contact our dedicated patient coordinators today to schedule your appointment or discuss any questions about the testing process.

Call or WhatsApp: +1(267) 388-9828

Take the first step toward understanding your genetic cardiac risk profile and empower yourself with knowledge for better health decisions. Our team is committed to providing compassionate, comprehensive care throughout your genetic testing experience.